Evidence map›Paper›PMID 29977520›Full record

ReviewTherapeutic advances in psychopharmacology2018

Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

Tomasz Litwin, Petr Dusek, Tomasz Szafrański, Karolina Dzieżyc, Anna Członkowska, Janusz K Rybakowski

Open access · hybridAbstract readReview
In one paragraph

Review in Therapeutic advances in psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Quality of Life in Wilson's Disease: A Systematic Literature Review.Journal of health economics and outcomes research · 2021
    Pooled it
  2. Sleep disorders in Wilson disease: a systematic review and meta-analysis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2020
    Pooled it
  3. Wilson disease revealed after febrile scrub typhus infection: the value of slit-lamp examination in pediatric encephalopathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  4. Review
  5. Neuropsychiatric manifestations of Wilson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  6. Article
  7. Article
  8. Improvement in sleep following treatment initiation in newly diagnosed, treatment-naïve patients with Wilson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  9. Wilson's disease with psychiatric symptoms: a case report.Journal of medical case reports · 2025
    Article
  10. Article
  11. Article
  12. A functional seizure case in Wilson's disease.Epilepsy & behavior reports · 2025
    Article
  13. Observational
  14. Review
  15. Article
  16. Can Parkinsonism be a solitary manifestation of Wilson's Disease?Clinical parkinsonism & related disorders · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Psychiatric Symptoms in Wilson's Disease-Consequence ofInternational journal of molecular sciences · 2024
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tomasz LitwinSecond Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Polandc.
Petr DusekDepartment of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
Tomasz SzafrańskiSpecialist Medical Practice Tomasz Szafrański, Warsaw, Poland.
Karolina DzieżycSecond Department of Neurology, Institute Psychiatry and Neurology, Warsaw, Poland.
Anna CzłonkowskaSecond Department of Neurology, Institute Psychiatry and Neurology, Warsaw, Poland.
Janusz K RybakowskiDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Institute of Psychiatry and Neurology · PLGeneral University Hospital in Prague · CZPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy.

Indexed as

behavioral disturbancescognitive deficitsmood disturbancespsychiatric symptomspsychosistreatmentWilson’s disease

Identifiers

PMID29977520
PMCPMC6022881
OpenAlexW2791786000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.